Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-17
SponsorLaura Beth Kalvas

About this trial

The goal of this clinical trial is to understand how easy or difficult it is for critically ill children (4-17 years old) to have light therapy while in the pediatric ICU. Participants will have a light meter at their bedside to measure light levels. Each morning, a light box will be placed at their bedside. Children, family, and staff will be asked to completed feedback surveys regarding the light therapy. Study participation will continue for a maximum of 5 days.

Eligibility criteria

Qualifiers

Anticipated to remain admitted to the study hospital pediatric ICU for additional 48 hours

English-speaking parent/legally authorized representative available at the bedside

Disqualifiers

Patients unable to open their eyes to receive light therapy (Glasgow Coma Scale eye opening score of 1 or neuromuscular blockade)

Patients with contraindications to light therapy (e.g., migraines, retinal disease, diseases associated with retinal complications, blindness, bipolar disorder, seizure disorder, traumatic brain injury)

Suspected/identified neglect/abuse, Child Protective Services involvement, or ward of state

Children receiving palliative/end-of-life care

Trial design

Treatments tested in this trial

  • Light Therapy

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

Laura Beth Kalvas

Lead sponsor

Nationwide Children's Hospital

Sponsor institution

Nationwide Children's Hospital

Collaborator